0001437749-24-013751.txt : 20240429 0001437749-24-013751.hdr.sgml : 20240429 20240429171219 ACCESSION NUMBER: 0001437749-24-013751 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240425 FILED AS OF DATE: 20240429 DATE AS OF CHANGE: 20240429 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Demopulos Gregory A MD CENTRAL INDEX KEY: 0001472160 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34475 FILM NUMBER: 24892679 MAIL ADDRESS: STREET 1: 201 ELLIOTT AVENUE WEST CITY: SEATTLE STATE: WA ZIP: 98119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OMEROS CORP CENTRAL INDEX KEY: 0001285819 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 911663741 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 ELLIOTT AVENUE WEST CITY: SEATTLE STATE: WA ZIP: 98119 BUSINESS PHONE: 206-676-5000 MAIL ADDRESS: STREET 1: 201 ELLIOTT AVENUE WEST CITY: SEATTLE STATE: WA ZIP: 98119 4 1 rdgdoc.xml FORM 4 X0508 4 2024-04-25 0001285819 OMEROS CORP OMER 0001472160 Demopulos Gregory A MD 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 1 1 Chairman, CEO & President 0 Stock Option (right to buy) 3.06 2024-04-25 4 A 0 725000 0 A 2034-04-25 Common Stock 725000 725000 D This option shall vest and become exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2024. Installments vest and become exercisable on each monthly anniversary thereafter. /s/ Peter B. Cancelmo 2024-04-29